Hepatogastroenterology and infectious diseases at Al-Azhar University, Egypt
Dr. Samy Zaky El-Sayed Kersh is a distinguished expert in hepatology, gastroenterology, and infectious diseases, with over three decades of experience in clinical practice, research, and education. Serving as Professor Emeritus at Al-Azhar University and holding leadership roles in national health committees, he has significantly contributed to advancing medical science and public health in Egypt. His research is well-recognized, with a ResearchGate h-index of 17 and over 3,785 citations. Dr. Kersh has been actively involved in global collaborations, international conferences, and advanced training programs, enhancing his expertise in cutting-edge techniques like GIT endoscopy and stem cell therapy. A committed educator, he has trained numerous undergraduate and postgraduate students. His membership in prestigious organizations and participation in public health initiatives, such as the COVID-19 Scientific Committee, reflect his dedication to improving healthcare outcomes. Dr. Kersh’s impactful career makes him a leading figure in his field.
Professional Profile
Education
Dr. Samy Zaky El-Sayed Kersh has a comprehensive and distinguished educational background in medicine, with a focus on tropical medicine, hepatology, and infectious diseases. He earned his M.B.B.Ch. from Al-Azhar University in 1982, followed by a Diploma in General Medicine in 1986 and a Diploma in Pediatric Medicine from Ain Shams University in 1989. He pursued his Master’s degree in Tropical Medicine at Cairo University in 1991 and achieved his M.D. in Tropical Medicine from Al-Azhar University in 1999. Throughout his academic journey, Dr. Kersh has continuously enhanced his knowledge through specialized training and certifications, including intensive care, GIT endoscopy, ultrasonography, and advanced diagnostic techniques. His diverse and multidisciplinary education reflects his commitment to advancing his expertise and addressing complex medical challenges in hepatology, gastroenterology, and infectious diseases, positioning him as a highly knowledgeable and skilled professional in his field.
Professional Experience
Dr. Samy Zaky El-Sayed Kersh boasts a distinguished professional career spanning over three decades in hepatology, gastroenterology, and infectious diseases. He serves as Professor Emeritus at the Faculty of Medicine for Girls, Al-Azhar University, and Head of the Hepatogastroenterology Department at Cairo-Fatiemic Hospital. Dr. Kersh has held leadership positions, including Head of the Infectious Diseases Scientific Committee and member of Egypt’s COVID-19 Scientific Committee under the Ministry of Health. His expertise encompasses advanced diagnostic and therapeutic procedures, such as GIT endoscopy, ultrasonography, and interventions like radiofrequency ablation and stem cell therapy. A committed educator, he has trained countless undergraduate and postgraduate students while contributing to national health initiatives, such as the Viral Hepatitis Prevention Program. Additionally, Dr. Kersh is a sought-after speaker and course director, sharing his knowledge through numerous local and international conferences, making him a prominent figure in medical practice and research.
Research interest
Dr. Samy Zaky El-Sayed Kersh’s research interests lie at the intersection of hepatology, gastroenterology, and infectious diseases, with a focus on advancing diagnostic and therapeutic approaches for liver and gastrointestinal disorders. His work encompasses areas such as the use of ultrasonography and endoscopic techniques for the management of hepatocellular carcinoma, variceal bleeding, and other complications of liver disease. Dr. Kersh has a keen interest in exploring innovative treatments, including stem cell therapy for end-stage liver disease and advanced interventional procedures for gastrointestinal conditions. He is also dedicated to studying the epidemiology and management of infectious diseases, contributing to public health initiatives such as viral hepatitis prevention and COVID-19 response efforts. With numerous publications in reputable journals and active participation in international research collaborations, Dr. Kersh continues to advance medical knowledge and improve clinical outcomes in his specialized fields of interest.
Award and honor
Dr. Samy Zaky El-Sayed Kersh has received numerous awards and honors throughout his illustrious career, reflecting his outstanding contributions to hepatology, gastroenterology, and infectious diseases. He has been recognized both nationally and internationally for his clinical expertise, research innovations, and dedication to medical education. Among his notable achievements, Dr. Kersh has earned CME accreditations from prestigious global organizations, including the American Association for the Study of Liver Diseases (AASLD) and the United European Gastroenterology (UEG). His leadership roles, such as heading the Infectious Diseases Scientific Committee and his involvement in Egypt’s COVID-19 Scientific Committee, further underscore his impact on public health. Additionally, Dr. Kersh’s membership in esteemed professional societies like the European Society of Gastrointestinal Endoscopy and the European Association for the Study of the Liver highlights his standing in the global medical community, marking him as a highly respected and honored medical professional.
Conclusion
Dr. Samy Zaky El-Sayed Kersh exhibits exemplary credentials in academic, clinical, and research domains, making him a strong candidate for the Best Faculty Award. His extensive contributions to medical education, leadership in national health programs, and impactful research align with the criteria of excellence for such an award. Addressing the highlighted areas for improvement could enhance his already impressive profile, further solidifying his candidacy. In summary, Dr. Kersh’s achievements underscore his suitability for the award, and his continued dedication to medical sciences ensures a lasting impact on both the academic and clinical communities.
Publicationstop Noted
- “Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses”
Authors: H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, …
Year: 2022
Citations: 290
- “Global multi-stakeholder endorsement of the MAFLD definition”
Authors: N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, …
Year: 2022
Citations: 203
- “Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa”
Authors: G Shiha, K Alswat, M Al Khatry, AI Sharara, N Örmeci, I Waked, …
Year: 2021
Citations: 150
- “Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children”
Authors: NI Girgis, Y Sultan, O Hammad, Z Farid
Year: 1995
Citations: 81
- “Changing Patterns of Acute Viral Hepatitis at a Major Urban Referral Center in Egypt”
Authors: S Zakaria, R Fouad, O Shaker, S Zaki, A Hashem, SSE Kamary, G Esmat, …
Year: 2007
Citations: 74
- “Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients”
Authors: R Eletreby, W Elakel, M Said, M El Kassas, S Seif, T Elbaz, M El Raziky, …
Year: 2017
Citations: 70
- “Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma”
Authors: MH Elnaggar, AI Abushouk, AHE Hassan, HM Lamloum, A Benmelouka, …
Year: 2021
Citations: 52
- “Knowledge, applicability, and barriers of telemedicine in Egypt: a national survey”
Authors: M Alboraie, MA Allam, N Youssef, M Abdalgaber, F El-Raey, N Abdeen, …
Year: 2021
Citations: 47
- “Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma”
Authors: M Azab, S Zaki, AG El-Shetey, MF Abdel-Moty, NMG Alnoomani, …
Year: 2011
Citations: 42
- “Ceftriaxone versus chloramphenicol for treatment of acute typhoid fever”
Authors: OM Hammad, T Hifnawy, D Omran, MA El Tantawi, NI Girgis
Year: 2011
Citations: 42
- “Comparison Between Insecticidal Activity of Lantana camara Extract and its Synthesized Nanoparticles Against Anopheline mosquitoes”
Authors: N Abd El Hafiz Hassanain, M Shaapan, M Abd El Hafiz Hassanain, …
Year: 2019
Citations: 41
- “Prevalence, risk factors and impacts of schistosomal and intestinal parasitic infections among rural school children in Sohag Governorate”
Authors: HM El-Masry, YA Ahmed, AA Hassan, S Zaky, ES Abd-Allah, …
Year: 2007
Citations: 37
- “Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients”
Authors: MA Eldosoky, R Hammad, AA Elmadbouly, RB Aglan, SG AbdelHamid, …
Year: 2023
Citations: 33
- “Egyptian recommendations for management of Helicobacter pylori infection: 2018 report”
Authors: M Alboraie, W Elhossary, OA Aly, B Abbas, L Abdelsalam, D Ghaith, …
Year: 2019
Citations: 33
- “Significance of glypican-3 in early detection of hepatocellular carcinoma in cirrhotic patients”
Authors: AM Tahon, MZ El-Ghanam, S Zaky, TM Emran, AM Bersy, F El-Raey, E AZ, …
Year: 2019
Citations: 32
